参考文献/References:
[1] 傅文玉,黄岩.黑质,纹状体与帕金森病[J].解剖科学进展,1997,3(1):51-56.
[2] Bjorklund A,Dunnett SB.Dopamine neuron systems in the brain:an update[J].Trends Neurosci,2007,30(5):194-202.
[3] Damier P,Hirsch EC,Agid Y,et al.The substantia nigra of the human brain - I.Nigrosomes and the nigral matrix,a compartmental organization based on calbindin D-28K immunohistochemistry[J].Brain,1999,122(8):1421-1436.
[4] Bisaglia M,Mammi S,Bubacco L.Kinetic and structural analysis of the early oxidation products of dopamine:analysis of the interactions with alpha-synuclein[J].J Biol Chem,2007,282(21):15597-15605.
[5] Zareba M,Bober A,Korytowski W,et al.The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems[J].Biochim Biophys Acta,1995,1271(2/3):343-348.
[6] Morris CM,Candy JM,Oakley AE,et al.Histochemical distribution of non-haem Iron in the human brain[J].Acta Anat(Basel),1992,144(3):235-257.
[7] Dormont D,Ricciardi KG,Tand D,et al.Is the subthalamic nucleus hypointense on T2-weighted images?A correlation study using Mr imaging and stereotactic Atlas data[J].AJNR Am J Neuroradiol,2004,25(9):1516-1523.
[8] Zecca L,Youdim MB,Riederer P,et al.Iron,brain ageing and neurodegenerative disorders[J].Nat Rev Neurosci,2004,5(11):863-873.
[9] Fedorow H,Tribl F,Halliday G,et al.Neuromelanin in human dopamine neurons:comparison with peripheral melanins and relevance to Parkinson's disease[J].Prog Neurobiol,2005,75(2):109-124.
[10] Jellinger KA.Neuropathology of sporadic parkinson's disease:evaluation and changes of concepts[J].Movement Disorders,2012,27(1):8-30.
[11] Damier P,Hirsch EC,Agid Y,et al.The substantia nigra of the human brain - II.Patterns of loss of dopamine-containing neurons in Parkinson's disease[J].Brain,1999,122(8):1437-1448.
[12] Mcritchie DA,Cartwright HR,Halliday GM.Specific a10 dopaminergic nuclei in the midbrain degenerate in parkinson's disease[J].Exp Neurol,1997,144(1):202-213.
[13] Sofic E,Paulus W,Jellinger K,et al.Selective increase of Iron in substantia nigra zona compacta of parkinsonian brains[J].J Neurochem,1991,56(3):978-982.
[14] Jellinger K,Kienzl E,Rumpelmair G,et al.Iron-melanin complex in substantia nigra of parkinsonian brains:an x-ray microanalysis[J].J Neurochem,1992,59(3):1168-1171.
[15] Double KL,Halliday GM.New face of neuromelanin[J].Journal of Neural Transmission-supplement,2006,70)(70):119-123.
[16] Hirsch WL,Kemp SS,Martinez AJ,et al.Anatomy of the brain-stem-correlation of invitro mr images with histologic sections[J].American Journal of Neuroradiology,1989,10(5):923-928.
[17] Flannigan BD,Bradley WG,Jr,et al.Magnetic resonance imaging of the brainstem:normal structure and basic functional anatomy[J].Radiology,1985,154(2):375-383.
[18] Braffman BH,Grossman RI,Goldberg HI,et al.Mr imaging of Parkinson disease with spin-echo and gradient-echo sequences[J].AJR Am J Roentgenol,1989,152(1):159-165.
[19] Drayer BP,Olanow W,Burger P,et al.Parkinson plus syndrome:diagnosis using high field Mr imaging of brain Iron[J].Radiology,1986,159(2):493-498.
[20] Pujol J,Junque C,Vendrell P,et al.Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease[J].Arch Neurol,1992,49(11):1119-1122.
[21] Stern MB,Braffman BH,Skolnick BE,et al.Magnetic-resonance imaging in parkinsons-disease and parkinsonian syndromes[J].Neurology,1989,39(11):1524-1526.
[22] Duguid JR,Delapaz R,Degroot J.Magnetic-resonance-imaging of the midbrain in parkinsons-disease[J].Ann Neurol,1986,20(6):744-747.
[23] Sasaki M,Shibata E,Tohyama K,et al.Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease[J].Neuroreport,2006,17(11):1215-1218.
[24] Enochs WS,Petherick P,Bogdanova A,et al.Paramagnetic metal scavenging by melanin:Mr imaging[J].Radiology,1997,204(2):417-423.
[25] Keren NI,Lozar CT,Harris KC,et al.In vivo mapping of the human locus coeruleus[J].Neuroimage,2009,47(4):1261-1267.
[26] Yao B,Li TQ,Van Gelderen P,et al.Susceptibility contrast in high field MRI of human brain as a function of tissue Iron content[J].Neuroimage,2009,44(4):1259-1266.
[27] Blazejewska AI,Schwarz ST,Pitiot A,et al.Visualization of nigrosome 1 and its loss in PD:pathoanatomical correlation and in vivo 7 T MRI[J].Neurology,2013,81(6):534-540.
[28] Cho ZH,Oh SH,Kim JM,et al.Direct visualization of parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging[J].Movement Disorders,2011,26(4):713-718.
[29] Cosottini M,Frosini D,Pesaresi I,et al.MR imaging of the substantia nigra at 7 T enables diagnosis of parkinson disease[J].Radiology,2014,271(3):831-838.
[30] Dae-Hyuk KM,Phd JM,Oh SH,et al.Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease[J].Ann Neurol,2012,71(2):267-277.
[31] Schwarz ST,Afzal M,Morgan PS,et al.The `swallow tail' appearance of the healthy nigrosome - A new accurate test of parkinson's disease:a Case-Control and retrospective Cross-Sectional MRI study at 3T[J].PLoS One,2014,9(4):e93814-e93814.
[32] Fearnley JM,Lees AJ.Ageing and parkinson's disease:substantia nigra regional selectivity[J].Brain,1991,114(Pt 5):2283-2301.
[33] Oikawa H,Sasaki M,Tamakawa Y,et al.The substantia nigra in Parkinson disease:proton density-weighted spin-echo and fast short inversion time inversion-recovery Mr findings[J].American Journal of Neuroradiology,2002,23(10):1747-1756.
[34] Peran P,Cherubini A,Assogna F,et al.Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature[J].Brain,2010,133(11):3423-3433.
[35] Lehericy S,Sharman MA,Dos Santos CL,et al.Magnetic resonance imaging of the substantia nigra in Parkinson's disease[J].Movement Disorders,2012,27(7):822-830.
[36] Hutchinson M,Raff U,Lebedev S.MRI correlates of pathology in parkinsonism::segmented inversion recovery ratio imaging(SIRRIM)[J].Neuroimage,2003,20(3):1899-1902.
[37] Menke RA,Scholz J,Miller KL,et al.MRI characteristics of the substantia nigra in Parkinson's disease:A combined quantitative T1 and DTI study[J].Neuroimage,2009,47(2):435-441.
[38] Minati L,Grisoli M,Carella F,et al.Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging[J].American Journal of Neuroradiology,2007,28(2):309-313.
[39] Ziegler DA,Wonderlick JS,Ashourian PA,et al.Substantia nigra volume loss before basal forebrain degeneration in early parkinson disease[J].JAMA Neurol,2013,70(2):241-247.
[40] Menke RA,Jbabdi S,Miller KL,et al.Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease[J].Neuroimage,2010,52(4):1175-1180.
[41] Schwarz ST,Rittman T,Gontu V,et al.T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease[J].Mov Disord,2011,26(9):1633-1638.
[42] Ohtsuka C,Sasaki M,Konno K,et al.Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive Mr imaging[J].Neurosci Lett,2013,541:93-98.
[43] Haacke EM,Makki M,Ge Y,et al.Characterizing Iron deposition in multiple sclerosis lesions using susceptibility weighted imaging[J].J Magn Reson Imaging,2009,29(3):537-544.
[44] Zhang JQ,Zhang YL,Wang J,et al.Characterizing Iron deposition in Parkinson's disease using susceptibility-weighted imaging:An in vivo Mr study[J].Brain Res,2010,1330:124-130.
[45] Anik Y,Iseri P,Demirci A,et al.Magnetization transfer ratio in early period of Parkinson disease[J].Acad Radiol,2007,14(2):189-192.
[46] Tambasco N,Belcastro V,Sarchielli P,et al.A magnetization transfer study of mild and advanced Parkinson's disease[J].European Journal of Neurology,2011,18(3):471-477.
[47] Eckert T,Sailer M,Kaufmann J,et al.Differentiation of idiopathic Parkinson's disease,multiple system atrophy,progressive supranuclear palsy,and healthy controls using magnetization transfer imaging[J].Neuroimage,2004,21(1):229-235.
[48] Du G,Lewis MM,Styner M,et al.Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease[J].Mov Disord,2011,26(9):1627-1632.
[49] Vaillancourt DE,Spraker MB,Prodoehl J,et al.High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease[J].Neurology,2009,72(16):1378-1384.
[50] Groeger A,Chadzynski G,Godau J,et al.Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease[J].Eur Radiol,2011,21(9):1962-1969.
[51] Choe BY,Park JW,Lee KS,et al.Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy[J].Invest Radiol,1998,33(8):450-455.
[52] Oz G,Terpstra M,Tkac I,et al.Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla:Detection of high GABA concentrations[J].Magnetic Resonance in Medicine,2006,55(2):296-301.
[53] Mueller C,Pinter B,Reiter E,et al.Visualization of nigrosome 1 and its loss in pd:pathoanatomical correlation and in vivo 7t mri[J].Neurology,2014,82(19):1752.
[54] Reiter E,Mueller C,Pinter B,et al.Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism[J].Movement Disorders,2015,30(8):1068-1076.